MAX BioPharma, Inc. Employee Directory

MAX BioPharma, Inc. Global Highlights

Location

Employees

North America

16

• United States Of America
  16

South America

1

• Brazil
  1

North America accounts for 94% of MAX BioPharma, Inc.'s workforce, followed by South America (6%).

MAX BioPharma, Inc.'s Leadership

• 
  J. F.

  Chief Executive Officer

  Mobile Phone

  Email
• 
  F. S.

  Director

  Mobile Phone

  Email

MAX BioPharma, Inc. Employee Metrics

• Business
• Marketing
• Other

Contact profiles from MAX BioPharma, Inc.

• 
  J. F.

  Chief Executive Officer

  Mobile Phone

  Email

  Oct 23, 2024
• 
  F. S.

  Director

  Mobile Phone

  Email

  Jul 07, 2024

• 1

Frequently Asked Questions

Where are MAX BioPharma, Inc.'s employees located?

MAX BioPharma, Inc. has about 12 employees across 2 continents, most of them in North America. North America accounts for 94% of MAX BioPharma, Inc.'s workforce, followed by South America (6%). By country, the largest groups are United States Of America (94%) and Brazil (6%).

How many employees does MAX BioPharma, Inc. have currently?

MAX BioPharma, Inc. has approximately 12 employees as of September 2026. These team members are located across 2 continents, including North America and South America.

Who are MAX BioPharma, Inc.'s key employees and leadership?

As of September 2026, MAX BioPharma, Inc.'s key employees include:

• Chief Executive Officer: J. F.
• Director: F. S.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

What is MAX BioPharma, Inc.'s most common email format?

MAX BioPharma, Inc. employees' email format typically follows the pattern of FLast@maxbiopharma.com. Trying to find reliable and up-to-date employee contact data? Find more MAX BioPharma, Inc. email formats with LeadIQ.

What is MAX BioPharma, Inc. known for?

MAX BioPharma, Inc. was founded in 2011 and operates in the Biotechnology Research industry. Explore MAX BioPharma, Inc.'s company overview page for more information.